Abstract: An organic electroluminescence device (OLED) of an embodiment includes a first electrode, a second electrode, and an emission layer disposed between the first electrode and the second electrode The emission layer may include a condensed polycyclic compound represented by Formula 1, which is connected to two or three substituents represented by Formula 2, and the OLED may exhibit excellent luminous efficiency:
Abstract: An ink set includes a first ink containing the compound represented by formula (y-1) or its salt, a second ink containing one or two or more of the compound represented by formula (m-1) or its salt, the compound represented by formula (m-2) or its salt, a compound represented by formula (m-3) or its salt, and the compound represented by formula (m-4) or its salt, and a third ink containing one or two or more of a compound represented by formula (c-1) or its salt, the compound represented by formula (c-2) or its salt, the compound represented by formula (c-3) or its salt, a compound represented by formula (c-4) or its salt, and the compound represented by formula (c-5) or its salt.
Abstract: The present disclosure relates to compounds of Formula (I), (II), or (III) as compounds capable of emitting delayed fluorescence, and uses of these compounds in organic light-emitting diodes.
Type:
Grant
Filed:
December 19, 2018
Date of Patent:
February 7, 2023
Assignee:
KYULUX, INC.
Inventors:
Yoshitake Suzuki, Shuo-Hsien Cheng, Yu Seok Yang, Jorge Aguilera-Iparraguirre, Rafael Gomez-Bombarelli, Timothy D. Hirzel
Abstract: A trichlorogermanide of formula (I): [R4N]/[R4P]Cl[GeCl3] (I), where R is Me, Et, iPr, nBu, or Ph, tris(trichlorosilyl)germanide of formula (II): [R4N]/[R4P][Ge(SiCl3)3] (II), where R is Me, Et, iPr, nBu, or Ph, a tris(trichlorosilyl)germanide adduct of GaCl3 of formula (III): [Ph4P][Ge(SiCl3)3*GaCl3], and a tris(trichlorosilyl)germanide adduct of BBr3 of formula (IV): [Ph4P][Ge(SiCl3)3*BBr3]. Also, methods for preparing the trichlorogermanides of formula (I), the tris(trichlorosilyl)germanide of formula (II), the tris(trichlorosilyl)germanide adduct of BBr3 of formula (IV).
Abstract: Aspects of the disclosure includes methods for preparing an amorphous solid composition of a fatty acid metal salt. In practicing the subject methods according to certain embodiments, a succinylated 3-(fatty acid amido)-2-hydroxy-1-(protected hydroxy)-propane organic salt is contacted with a metal base to produce a succinylated 3-(fatty acid amido)-2-hydroxy-1-(protected hydroxy)-propane metal salt; and the succinylated 3-(fatty acid amido)-2-hydroxy-1-(protected hydroxy)-propane metal salt is precipitated in a solvent to produce an amorphous solid succinylated 3-(fatty acid amido)-2-hydroxy-1-(protected hydroxy)-propane metal salt composition. An amorphous solid succinylated 3-(fatty acid amido)-2-hydroxy-1-(protected hydroxy)-propane lithium salt is also provided.
Abstract: Molybdenum(0) coordination complexes comprising at least one cycloheptatriene ligand and optionally one or more neutral ligands which coordinate to the metal center by carbon, nitrogen or phosphorous are described. Methods for depositing molybdenum-containing films on a substrate are described. The substrate is exposed to a molybdenum precursor and a reactant to form the molybdenum-containing film (e.g., elemental molybdenum, molybdenum oxide, molybdenum carbide, molybdenum silicide, molybdenum nitride). The exposures can be sequential or simultaneous.
Type:
Grant
Filed:
January 12, 2021
Date of Patent:
December 20, 2022
Assignee:
APPLIED MATERIALS, INC.
Inventors:
Andrea Leoncini, Paul Mehlmann, Nemanja Dordevic, Han Vinh Huynh, Doreen Wei Ying Yong
Abstract: The invention relates to novel compounds that are useful for modulating cellular ROS. The compounds are amide-derivatives of 2-hydroxy-2-methyl-4-(3,5,6-trimethyl-1,4-benzoquinon-2-yl)-butanoic acid. The compounds of the invention are formulated into pharmaceutical or cosmetic compositions. The invention further relates to methods wherein the compounds of the invention are used for treating or preventing diseases associated with increased ROS levels mitochondrial disorders and/or conditions associated with mitochondrial dysfunction, including adverse drug effects. The invention also relates to cosmetic methods for treating or delaying further aging of the skin and veterinary applications.
Type:
Grant
Filed:
September 18, 2020
Date of Patent:
December 20, 2022
Assignee:
Khondrion IP B.V.
Inventors:
Julien David Beyrath, Mina Pellegrini, Petrus Maria van Zandvoort, Johannes Albertus Maria Smeitink
Abstract: Enzyme-immobilizing MOFs and methods for their use in enzymatically catalyzed reactions are provided. The MOFs are channel-type MOFs that present a hierarchical pore structure comprising a first set of large channels sized for enzyme immobilization and a second set of smaller channels running alongside of the large channels that remain enzyme-free and allow for reactant delivery to the enzymes and product expulsion from the larger channels.
Type:
Grant
Filed:
May 25, 2017
Date of Patent:
December 20, 2022
Assignee:
Northwestern University
Inventors:
Omar K. Farha, Peng Li, Justin A. Modica, Milan Mrksich, Joseph T. Hupp
Abstract: Disclosed herein is a method of forming a compound of formula I: wherein the substituents are defined in the specification. In particular, the compounds of formula I can be converted to amino acids bearing quaternary stereocenters with exceptional optical purities.
Abstract: The present disclosure relates to an aromatic amine derivative represented by general formula (I). The aromatic amine derivative has fluorescence emission at a short light emission wavelength, and the light-emission spectrum of the aromatic amine derivative has a narrow half-peak width, and accordingly, the material has deep-blue fluorescence emission and has a very-high light emission efficiency. An organic electroluminescent component prepared by using the aromatic amine derivative has deep-blue color coordinates, a high light emission efficiency and a long life-span.
Abstract: The invention describes single-site metal catalysts such as Pt single-site centers on powdered oxide supports with a 1,10-phenanthroline-5,6-dione (PDO) or bis-pyrimidyltetrazine (BMTZ) ligand on powdered MgO, Al2O3, or CeO2.
Abstract: Provided is a method for efficiently producing ferric citrate hydrate with high purity and various specific surface areas. The method for producing modified ferric citrate hydrate includes a step of bringing a solution containing water, citric acid, and ferric citrate as a material into contact with water-soluble organic solvent.
Abstract: Molybdenum(IV) and molybdenum(III) coordination complexes are described. Methods for depositing molybdenum-containing films on a substrate are described. The substrate is exposed to a molybdenum precursor and a reactant to form the molybdenum-containing film (e.g., elemental molybdenum, molybdenum oxide, molybdenum carbide, molybdenum silicide, molybdenum nitride). The exposures can be sequential or simultaneous.
Type:
Grant
Filed:
January 12, 2021
Date of Patent:
October 4, 2022
Assignee:
Applied Materials, Inc.
Inventors:
Andrea Leoncini, Paul Mehlmann, Nemanja Dordevic, Han Vinh Huynh, Doreen Wei Ying Yong
Abstract: The present disclosure provides novel metal-organic framework materials (MOFs) useful, for example, for gas adsorption, storage, and/or separation. Also provided are methods of making the MOFs, articles of manufacture incorporating the MOFs and methods for making these, as well as methods of using the MOFs.
Type:
Grant
Filed:
July 17, 2018
Date of Patent:
September 27, 2022
Assignees:
Zymergen Inc., The Regents of the University of Michigan, The United States of America as Represented by the Secretary of the Army
Inventors:
Adam Safir, Adam J. Matzger, Shantel Leithead, Jialiu Ma, Gregory W. Peterson, John McNamara
Abstract: A viscoelastic surfactant (VES) for a self-diverting acid under high temperature has a structural formula shown as formula (I), wherein, n is saturated hydrocarbon with 2 to 8 carbon atoms; R1 is saturated or unsaturated hydrocarbon with 18 to 28 carbon atoms; R2 and R3 are independently methyl, ethyl or hydrogen, and R2 and R3 can be the same or different; and X? is any one of Cl?, Br?, CO32?, SO42?, HCOO? and CH3COO?. The method for preparing the surfactant includes subjecting a fatty acid and an organic amine to acid-amine condensation to obtain an intermediate. The intermediate reacts with a metal hydride to obtain a fatty amine. Then, an acid solution is used to protonate the fatty amine to obtain an ultra-long-chain viscoelastic cationic surfactant. The present invention also provides use of the surfactant as a thickener for a self-diverting acid.
Abstract: Provided are a novel metal triamine compound, a method for preparing the same, a composition for depositing a metal-containing thin film including the same, and a method for preparing a metal-containing thin film using the same. The metal triamine compound of the present invention has excellent reactivity, is thermally stable, has high volatility, and has high storage stability, and thus, it may be used as a metal-containing precursor to easily prepare a high-purity metal-containing thin film having high density.
Type:
Grant
Filed:
April 26, 2018
Date of Patent:
September 20, 2022
Assignee:
DNF CO., LTD.
Inventors:
Myong Woon Kim, Sang Ick Lee, Sang Jun Yim, Won Mook Chae, Jeong Hyeon Park, Kang Yong Lee, A Ra Cho, Joong Jin Park, Heang Don Lim
Abstract: Thioesters, thiocarbamates, thiocarbazates, semithiocarbazates, peptides, aza-amino acid conjugates, and azapeptides; and a chemoselective and site-specific functionalization protocol of protected thiocarbazates and semithiocarbazates are described. The protocol features the use of Mitsunobu reaction to alkylate specifically the nitrogen atom close to the acylthiol moiety with alcohols to produce protected mono-substituted thiocarbazates that can be stored for months, activated under mild conditions at low temperature using halonium reagents and integrated orthogonally to make substituted semicarbazides that can be used, e.g., as synthons in synthesis of aza-amino acid conjugates, azapeptides and other peptidomimetics.
Type:
Grant
Filed:
May 8, 2020
Date of Patent:
September 13, 2022
Assignee:
THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH
Abstract: Described herein are cobalt compounds, processes for making cobalt compounds, cobalt compounds used as precursors for depositing cobalt-containing films (e.g., cobalt, cobalt oxide, cobalt nitride, cobalt silicide etc.); and cobalt films. Examples of cobalt precursor compounds are bis(diazadiene)cobalt compounds. Examples of surfaces for deposition of metal-containing films include, but are not limited to, metals, metal oxides, metal nitrides, and metal silicates; silicon, silicon oxide and silicon nitride. Alkylated diazadiene ligands are used to form cobalt complexes which are used for selective deposition on certain surfaces and/or superior film properties such as uniformity, continuity, and low resistance.
Type:
Grant
Filed:
June 3, 2019
Date of Patent:
September 13, 2022
Assignee:
Versum Materials US, LLC
Inventors:
Alan C. Cooper, Sergei V. Ivanov, Christopher David Hopkins, Moo-Sung Kim